[EL-10] Reinforced molecular targeted therapy for Ph+ Leukemias based on risk-benefit assessment
Abstract password authentication.
Password to view abstracts and 'Participants' page is announced on the e-blast sent to early-bird/advanced registrants on September 13. It is also on the page 7 of IATDMCT 2017 PROGRAM BOOK.